Buyback yield (TTM)
11.16%
Shareholder yield (TTM)
11.16%
5Y share count change
10.2%
Buyback spend (TTM)
$1.00B
Cumulative buybacks
$1.79B
Key takeaways
- DocuSign (DOCU) repurchased about $1.00B of stock over the trailing twelve months.
- Diluted share count is up 10.2% over the last ~5 fiscal years — equity issuance and stock-based compensation are outpacing repurchases.
- TTM buyback ÷ stock-based-comp ratio of 1.62× — repurchases more than cover SBC dilution.
- TTM repurchases used about 90% of free cash flow remaining after dividends.
Dividend & buyback yield over time for DocuSign (DOCU)
Stacked annual yields — buyback yield (TTM cash repurchases ÷ market cap) plus dividend yield from the same fiscal-year-end key-metrics period — show how total cash return per dollar of equity has evolved.
Diluted vs basic shares (annual) for DocuSign (DOCU)
Diluted weighted-average shares are the EPS denominator — a falling count means buybacks are outpacing SBC dilution.
Year-over-year change in diluted shares for DocuSign (DOCU)
Green is fewer shares vs the prior fiscal year (net repurchase); red is growth (dilution). The earliest year shown has no prior year to compare.
Cash buyback spend over time for DocuSign (DOCU)
Latest: $869.09M
Overview
The 2026 reading of DocuSign (DOCU) buyback spend is $869.09M – grew 27.1% year-over-year.
DocuSign buyback spend compound annual growth for the 2016–2026 (10 years) window is +39.0%, sustaining 4 straight years of year-over-year growth.
2026 marks the peak buyback spend at $869.09M, with the historical low of $0.00 recorded in 2018.
DocuSign Buyback Spend 2026: $869.09M
DocuSign posted buyback spend of $869.09M in 2026, grew 27.1% from 2025. This figure represents the highest annual value in the available history.
DocuSign Buyback Spend 2025: $683.53M
In 2025, DocuSign reported buyback spend of $683.53M, surged 369.7% from 2024.
DocuSign Buyback Spend 2024: $145.51M
DocuSign buyback spend in 2024 was $145.51M, surged 130.8% from 2023.
DocuSign Buyback Spend 2023: $63.04M
DocuSign buyback spend in 2023 was $63.04M.
DocuSign Buyback Spend 2022: $0.00
DocuSign buyback spend in 2022 was $0.00.
See more financial history for DocuSign (DOCU).
Buyback, SBC & dilution history
Buyback spend, SBC, net dilution effect, and share count.
| 2026 | $869.09M | $622.32M | $246.76M | 8.25% | 0.20B | -2.7% | |
| 2025 | $683.53M | $610.34M | $73.19M | 3.48% | 0.21B | +0.7% | |
| 2024 | $145.51M | $616.85M | −$471.33M | 1.16% | 0.21B | +4.0% | |
| 2023 | $63.04M | $538.73M | −$475.69M | 0.51% | 0.20B | +2.1% | |
| 2022 | $0.00 | $408.54M | −$408.54M | — | 0.20B | +5.9% | |
| 2021 | $0.00 | $286.88M | −$286.88M | — | 0.19B | +5.1% | |
| 2020 | $0.00 | $206.40M | −$206.40M | — | 0.18B | +30.7% | |
| 2019 | $0.00 | $410.98M | −$410.98M | — | 0.14B | +318.5% | |
| 2018 | $0.00 | $29.75M | −$29.75M | — | 0.03B | +15.3% | |
| 2017 | $85.00K | $35.44M | −$35.36M | — | 0.03B | 0.0% | |
| 2016 | $32.34M | $32.66M | −$320.00K | — | 0.03B | — |
- 2026$869.09M
- 2025$683.53M
- 2024$145.51M
- 2023$63.04M
- 2022$0.00
- 2021$0.00
- 2020$0.00
- 2019$0.00
- 2018$0.00
- 2017$85.00K
- 2016$32.34M
Buybacks vs stock-based compensation for DocuSign (DOCU)
Annual cash repurchases set against stock-based compensation. Coverage above 1× means buybacks fully offset the equity dilution from SBC. TTM coverage: 1.62×.
Buybacks vs dividends (share of cash returned) for DocuSign (DOCU)
How DocuSign splits cash returned to shareholders between dividends and buybacks.
Sector peers by buyback spend
Companies in the same sector as DocuSign, ranked by their latest buyback spend.
| $90.71B | |
| $40.09B | |
| $18.42B | |
| $6.65B | |
| $6.31B | |
| $1.32B | |
| $0.00 | |
| $0.00 |
- $90.71B
- $40.09B
- $18.42B
- $6.65B
- $6.31B
- $1.32B
- $0.00
Buyback capacity (TTM)
Free cash flow minus dividends paid versus actual TTM repurchases — the headroom bar shows how much of post-dividend FCF is still being deployed elsewhere.
Headroom $1.12B (TTM FCF − TTM dividends, clamped at zero).
Frequently asked questions
Data & methodology
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation